Fair value published on 18 Oct 2026, 15:05 CEST; previously $112 since 6 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 15:05 CEST.
Price used: $80.41 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
27.0% below
+36.9% to fair value
ACCE score
54
out of 100
Analysts
100% buy
2 covering
P/E
21.2x
forward 14.3x
1-year return
+21.3%
Dividend yield
0.00%
Cimpress plc Ordinary Shares (Ireland) in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Cimpress makes mass-customised print and promotional products sold online under brands including Vistaprint, Printi and Pixartprinting, along with its Upshop and Drukwerkdeal businesses. Its edge is a large, automated production network and a small-business customer base that buys repeatedly, which gives it scale in short-run printing that most local competitors cannot match. Revenue growth of 8.7% and a 46.1% gross margin show the top line is still expanding at a healthy clip, though a 6.3% operating margin leaves little room for error. The stock trades at 20.6 times trailing earnings and 16.9 times forward, so the market is pricing in a meaningful earnings recovery that the margin structure has to deliver. Whether that recovery shows up in operating income, rather than in revenue alone, is the question that justifies a closer look.
⚠ Investor warnings · 5 flagsAI-assisted·How I use AI
high
Earnings declining despite sales growth
Revenue grew 8.7% year over year, yet earnings fell 17.4%, and quarter-on-quarter revenue dropped 15.0%. Margin pressure is eating into the top-line gains.
moderate
Heavy short interest
Short interest stands at 15.2% of shares, a high level that signals meaningful bearish positioning and can amplify volatility in either direction.
moderate
Score slipping over 90 days
The ACCE score fell 5 points, from 57 to 52, over 90 days, with growth at 40 and quality at 37, both weak.
moderate
Insider selling without buying
Recent disclosed insider activity shows $4.72M in sales and no buys, a one-directional pattern worth noting alongside 10.1% insider ownership.
moderate
Negative book equity
Debt to equity sits at -3.55 and ROE is 0.0%, meaning the balance sheet carries a negative equity base that makes leverage hard to read at face value.
AI research notes
AI-assisted·How I use AIWritten Oct 18, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 8.7% over the last year, in line with the 7.7% average annual growth over five years.
Free cash flow of $183M over the last twelve months gives a 9.9% yield at the current share price.
The stock trades at 16.9x forward earnings against a sector median of 23.6x, and the share count fell 1.2% last year.
Why it could disappoint
The stock trades 27.0% below the model fair value of $110.12, but the 3 of 4 models in the consensus set that gap.
A 2.6% net margin and a return on equity of 0.0% leave little room for error on a heavily indebted balance sheet.
The current price implies cash flow growth of 8.7% a year for five years, the same pace the company has just delivered, so little upside is priced in beyond that.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Oct 28, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where CMPR's valuation models land
Price
$80.41
Model fair value
$110
Model range
$65.29 to $147
Fair value $110
Price $80.41
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores